A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

NCT00099905 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

639

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: vildagliptin

Sponsor

Novartis Pharmaceuticals